Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal Junction
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the dose limiting toxicity and the maximum
tolerable dose of the radiochemotherapy with Docetaxel and Oxaliplatin in patients with
adenocarcinoma of the gastric-oesophageal junction.